Premier Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 9.00 Cr
as on 24-10-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.36 Cr
as on 24-10-2024
- Satisfied Charges ₹ 41.20 Cr
as on 24-10-2024
- Revenue 15.50%
(FY 2023)
- Profit 9.21%
(FY 2023)
- Ebitda 23.40%
(FY 2023)
- Net Worth 14.92%
(FY 2023)
- Total Assets 17.59%
(FY 2023)
About Premier Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 9.00 Cr.
The company currently has active open charges totaling ₹12.36 Cr. The company has closed loans amounting to ₹41.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arvind Iyer, Priyamvada Iyer, and Arjun Iyer serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC139209
- Company No.
139209
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2003
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Premier Nutraceuticals Private Limited offer?
Premier Nutraceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Multivitamin Tablets & Capsules, Antioxidant Capsule, Nutraceuticals & Dietary Supplements, Mineral Supplement, Calcium Tablet, Pharmaceutical Medicine, Fairness Cream, Skin Lightening Cream.
Who are the key members and board of directors at Premier Nutraceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Iyer  | Managing Director | 18-Feb-2003 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyamvada Iyer | Director | 18-Feb-2003 | Current |
| Arjun Iyer | Director | 09-Jun-2016 | Current |
Financial Performance of Premier Nutraceuticals.
Premier Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.5% increase. The company also saw a slight improvement in profitability, with a 9.21% increase in profit. The company's net worth Soared by an impressive increase of 14.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Premier Nutraceuticals?
In 2023, Premier Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Premier Global Marketing Private LimitedActive 17 years 1 monthArvind Iyer and Priyamvada Iyer are mutual person
Charges (Loans)
₹12.36 Cr
₹41.20 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 10.27 Cr
- Others : 1.05 Cr
- Indiabulls Housing Finance Limited : 1.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2024 | Bank Of India | ₹2.45 Cr | Open |
| 27 Sep 2022 | Bank Of India | ₹6.27 Cr | Open |
| 31 Jan 2022 | Bank Of India | ₹1.55 Cr | Open |
| 14 Feb 2018 | Others | ₹1.05 Cr | Open |
| 19 Mar 2015 | Indiabulls Housing Finance Limited | ₹1.04 Cr | Open |
How Many Employees Work at Premier Nutraceuticals?
Premier Nutraceuticals has a workforce of 161 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premier Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premier Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.